Login to Your Account



Future biomarker uses may be more future-oriented

By Anette Breindl
Science Editor

Tuesday, April 8, 2014
SAN DIEGO – The annual meeting of the American Association for Cancer Research (AACR) draws a broad mix of clinical and basic scientists, and so the gathering usually brings news of broad themes of cancer research – be they biomarkers, immunotherapies or clinical trial design – from both a theoretical and a practical standpoint. Biomarkers exemplified that dual strength this year.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription